ALZHEIMER'S DISEASE AND DEMENTIA WITH LEWY BODIES: SPECIAL FOCUS ON THE ROLE OF SERPINS

作者: Henrietta Nielsen

DOI:

关键词:

摘要: Serine protease inhibitors (Serpins) are involved in the pathogenesis of neurodegenerative dementia, including two most common types, Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB). The pathological characteristics AD include senile plaques, mainly composed aggregated amyloid-beta peptide (Abeta1-42), but also serpins, neurofibrillary tangles hyperphosphorylated tau protein. Pathological hallmarks DLB aggregates alpha-synuclein (Lewy bodies), however, co-existing pathology is frequently found. In present work, we have investigated role three namely alpha1-antichymyotrypsin, alpha1-antitrypsin neuroserpin, context DLB. We shown that alpha1-antichymotrypsin: (i) renders oligomer formation profile incubated Abeta1-42, favouring dimer formation; (ii) under certain conditions appears to protect Abeta1-42 from chymotrypsin digestion and;(iii) combination soluble forms significantly affects global gene expression primary fetal human astrocytes; (iv) can influence binding and, potentially, uptake adult astrocytes. clinical studies have: for first time, determined cerebrospinal fluid levels neuroserpin established a link as higher were found patients than non-demented controls patients; showed plasma alpha1-antichymotrypsin correlate lower cognitive function AD, respectively; (iii) intercellular adhesion molecule-1 platelet endothelial cell molecule-1. Our findings support statement inflammatory vascular mechanisms suggest serpins likely processes leading dysfunction. Further research needed assess distinct actions neurodegeneration dementia. (Less)

参考文章(273)
Masaki Takao, Merrill D. Benson, Jill R. Murrell, Masahide Yazaki, Pedro Piccardo, Frederick W. Unverzagt, Richard L. Davis, Peter D. Holohan, Daniel A. Lawrence, Rosemarie Richardson, Martin R. Farlow, Bernardino Ghetti, Neuroserpin Mutation S52R Causes Neuroserpin Accumulation in Neurons and Is Associated with Progressive Myoclonus Epilepsy Journal of Neuropathology & Experimental Neurology. ,vol. 59, pp. 1070- 1086 ,(2000) , 10.1093/JNEN/59.12.1070
Y. Harigaya, H. Yamaguchi, S. Hirai, M. Shoji, E. Matsubara, K. Ishiguro, Alpha 1-antichymotrypsin is present in diffuse senile plaques. A comparative study of beta-protein and alpha 1-antichymotrypsin immunostaining in the Alzheimer brain. American Journal of Pathology. ,vol. 138, pp. 247- 257 ,(1991)
K. A. Jellinger, Prevalence of vascular lesions in dementia with Lewy bodies. A postmortem study. Journal of Neural Transmission. ,vol. 110, pp. 771- 778 ,(2003) , 10.1007/S00702-003-0824-X
Rajesh N. Kalaria, Stephanie N. Kroon, Todd Golde, George Perry, Serine protease inhibitor antithrombin III and its messenger RNA in the pathogenesis of Alzheimer's disease. American Journal of Pathology. ,vol. 143, pp. 886- 893 ,(1993)
Thatte U, AN-1792 (Elan). Current opinion in investigational drugs. ,vol. 2, pp. 663- 667 ,(2001)
Praveen Ballabh, Alex Braun, Maiken Nedergaard, The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiology of Disease. ,vol. 16, pp. 1- 13 ,(2004) , 10.1016/J.NBD.2003.12.016
Sadako Fujinami, Shigeo Takada, Michio Tsuda, Masaichi Yamamura, Masahiko Matsumoto, Tsunehiko Katsunuma, Incorporation of Alpha-1-Antichymotrypsin into Human Stomach Adenocarcinoma Cell Nuclei and Inhibition of DNA Primase Activity The Tokai journal of experimental and clinical medicine. ,vol. 13, pp. 321- 327 ,(1988)
J Potempa, E Korzus, J Travis, The serpin superfamily of proteinase inhibitors: structure, function, and regulation. Journal of Biological Chemistry. ,vol. 269, pp. 15957- 15960 ,(1994) , 10.1016/S0021-9258(17)33954-6